Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Six-month Double-blind, Randomized, Placebo-controlled Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia

NCT00530127 is registered in ClinicalTrials.gov with ApoPharma as lead sponsor.

NCT NCT00530127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00530127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Six-month Double-blind, Randomized, Placebo-controlled Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Lead sponsor
ApoPharma
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2008
Completion date
July 31, 2009
Enrollment
80 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

friedreich's ataxia